N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

McCallum, Matthew, De Marco, Anna, Lempp, Florian A., Tortorici, M. Alejandra, Pinto, Dora, Walls, Alexandra C., Beltramello, Martina, Chen, Alex +26 more·2021·Cell
DOI 10.1016/j.cell.2021.03.028

Cited by (909)

Items 801–900 of 909

  1. Isolation of bat sarbecoviruses of SARS-CoV-2 clade, Japan
    Shin Murakami, Tomoya Kitamura, Hiromichi Matsugo, Haruhiko Kamiki, Ken Oyabu, Wataru Sekine, Akiko Takenaka‐Uema, Yuko Sakai‐Tagawa, Yoshihiro Kawaoka, Taisuke Horimoto · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  2. COVID‐19: Virology
    Saeideh Najafi, Salar Tofighi, Juliana Sobczyk · 2022
  3. Defining neutralization and allostery by antibodies against COVID-19 variants
    Nikhil Kumar Tulsian, Palur Venkata Raghuvamsi, Xinlei Qian, Yue Gu, Bhuvaneshwari D O Shunmuganathan, Firdaus Samsudin, Yee Hwa Wong, Jianqing Lin, Kiren Purushotorman, Mary Kozma et al. · 2023 · Research Square
  4. Monoclonal antibodies against human coronavirus NL63 spike
    Meghan Conlan, Hyon‐Xhi Tan, Robyn Esterbauer, Andrew Kelly, Stephen John Kent, Adam K. Wheatley, Wen Shi Lee · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  5. Broad and potent neutralizing mAbs are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection
    J. Seow, Z. A. Shalim, C. Graham, Simon Kimuda, Aswin Pillai, T. Lechmere, Ashwini Kurshan, Atika M. Khimji, L. Snell, G. Nebbia et al. · 2023 · bioRxiv
  6. Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
    Ketaren, Natalia E., Mast, Fred D., Fridy, Peter C., Olivier, Jean Paul, Sanyal, Tanmoy, Sali, Andrej, Chait, Brian T., Rout, Michael P., Aitchison, John D. · 2023
  7. Equivalent Binding Of Sera From Omicron And Delta Period To Future Omicron Subvariants
    Deepayan Biswas, Gokulnath Mahalingam, Rajesh Kumar Subaschandrabose, Sangeetha Priya, Rohini Ramachandran, Sevanthy Suresh, Tamil Venthan Mathivanan, Nelson Vijaykumar Balu, Kavitha Selvaraj, Arun Jose Nellickal et al. · 2023 · medRxiv
  8. Genetic Variations in Spike Protein and Linking SARS-CoV-2 Variants to Clinical Outcomes
    Peshnyar Muhammad Atta Rashid, Gaza Farag Salih · 2023 · Research Square
  9. Contrasting Effects of SARS-CoV-2 Vaccination vs. Infection on Antibody and TCR Repertoires
    Jasper Braun, Elliot D. Hill, Elisa Contreras, Michie Yasuda, Alexandra Morgan, Sarah Ditelberg, Ethan Winter, Cody J. Callahan, Gabrielle Mazzoni, Andrea Kirmaier et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  10. Rapid Emergence and Evolution of SARS-CoV-2 Variants in Advanced HIV Infection
    Sung Hee Ko, Pierce E. Radecki, Frida Belinky, Jinal N. Bhiman, Susan T. Meiring, Jackie Kleynhans, Daniel Gyamfi Amoako, Vanessa Guerra Canedo, Margaret Lucas, Dikeledi Kekana et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  11. Engineering customized viral receptors for various coronaviruses
    Peng Liu, Meiling Huang, Hua Guo, Junyu Si, Yuanmei Chen, Chunli Wang, Yu Xiao, Lulu Shi, Qing Xiong, Chenbao Ma et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  12. Genomics insights reveal multi-year maintenance of a new Deltacoronavirus infecting Seabirds from the Cagarras Island Archipelago Natural Monument, Brazil
    Yago José Mariz Dias, Alexandre Freitas da Silva, Allan Rodrigues, Fernanda Regis Gomes, Leonardo Corrêa, Paola Cristina Resende, Marilda Mendonça Siqueira, Marina Galvão Bueno, Tatiana Ribeiro, Paula Gabriela Quintana et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  13. The Effect of Hindlimb Studs on Movement Symmetry in Horses During Lungeing
    H. Sharp, Thilo Pfau, S. Hopkins · 2014 · Equine Veterinary Journal
  14. P.8.8 Basement membrane deposition during muscle development in the FKRP Deficient Mouse
    Jihee Kim, M. Fuente-Fernandez, Manoli Kavishwar, S. Brown · 2013 · Neuromuscular Disorders
  15. Identification of novel transcription factors that may regulate transcription of the equine chorionic gonadotrophin beta subunit
    Jordan Read, Victoria Cabrera-Sharp, Samantha M. Mirczuk, Robert C. Fowkes, Mestre Amanda de · 2015 · Endocrine Abstracts
  16. Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2
    Huibin Lv, O. Tsang, Ray T. Y. So, Yi-Quan Wang, M. Yuan, Hejun Liu, Garrick K. Yip, Q. Teo, Yihan Lin, Wei-Wen Liang et al. · 2021 · bioRxiv
  17. SARS-CoV-2 gained the unique spike protein S1-N-Terminal Domain from the promising pangolins mixing vessel: A novel clue for the pandemic outbreak
    Perumal Arumugam Desingu, K. Nagarajan · 2021 · Research Square
  18. Cutting epitopes to survive: the case of lambda variant
    Stefano Pascarella, Massimo Ciccozzi, Martina Bianchi, Domenico Benvenuto, Roberto Cauda, Antonio Cassone · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  19. Network analysis outlines strengths and weaknesses of emerging SARS-CoV-2 Spike variants
    Pedro D. Manrique, Sandipan Chakraborty, K. Nguyen, Rachael A. Mansbach, Bette Korber, Sandrasegaram Gnanakaran · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  20. Delta variant - A new phase of COVID-19 in India
    S S Sreenivas · 2021 · International Journal of Medical Science
  21. SARS-CoV-2 mRNA Vaccine Induces Robust Specific and Cross-Reactive IgG and Unequal Strain-Specific Neutralizing Antibodies in Naïve and Previously Infected Recipients
    Tara M. Narowski, Kristin Raphel, Lily E. Adams, Jenny Huang, Nadja A. Vielot, Ramesh Jadi, Aravinda M. deSilva, Ralph Steven Baric, John Lafleur, Lakshmanane Premkumar · 2021 · SSRN Electronic Journal
  22. Mapping the allosteric effects that define functional activity of SARS-CoV-2 specific antibodies
    Nikhil Kumar Tulsian, Palur Venkata Raghuvamsi, Xinlei Qian, Yue Gu, Bhuvaneshwari D O Shunmuganathan, Firdaus Samsudin, Yee Hwa Wong, Jianqing Lin, Kiren Purushotorman, Mary Kozma et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Structure, mutations and variants of Coronavirus 2 (SARS-CoV): A brief report
    Mohammad Farhan Qureshi, Hania Farhan, Shoeb Qureshi · 2022 · GSC Advanced Research and Reviews
  24. British Society for Matrix Biology Autumn 2017 Meeting: Translating the Matrix
    Juskaite, V, Corcoran, D, Leitinger, B · 2017 · International Journal of Experimental Pathology
  25. Uncovering the structural flexibility of SARS-CoV-2 glycoprotein spike variants
    Hiam R. S. Arruda, Túlio M. Lima, Renata G. F. Alvim, Fernanda B. A. Victorio, Daniel Paiva Barros de Abreu, Federico Francisco Marsili, Karen D. Cruz, Patricia Sosa‐Acosta, Mauricio Quiñones‐Vega, Jéssica de Siqueira Guedes et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  26. The Evolution of SARS-CoV-2
    Susan F. Bailey, Mahfuza Akter · 2022 · Springer eBooks
  27. A Visual Immunochromatographic Assay for Rapid Detection of SARS-CoV-2 Neutralizing Antibody
    Yong Tang, Ying Zhang, Yixiao Chen, Yizhe Li, Yong He, Jinyong He, Xiaoli Zhang, Zhixing Gao, Jianhua Xu · 2022 · SSRN Electronic Journal
  28. 急速に広がる南アフリカ型変異株は免疫応答を回避する
    2021 · Nature Digest
  29. [Progress on the development of the SARS-CoV-2 vaccine and antibody drugs].
    Si-Yu Xu, Dan Tang · 2022 · PubMed Central
  30. Development of pyrosequencing-based assay for genotyping of different coronavirus variants
    Anna K. Chistyakova, Ekaterina Stepanova, Исакова-Сивак Ирина Николаевна, Руденко Лариса Георгиевна · 2022 · Medical academic journal
  31. Enhanced stability of the SARS CoV-2 spike glycoprotein trimer following modification of an alanine cavity in the protein core
    Pantelis Poumbourios, Christine Langer, Irene Boo, Tasnim Zakir, Anouschka Akerman, Vanessa Milogiannakis, Anupriya Aggarwal, Stuart Grant Turville, Heidi E. Drummer · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  32. Evaluating the Effect of SARS-CoV-2 Spike Mutations by Causal Inference
    Xin Wang, Mingda Hu, Bo Liu, Huifang Xu, Yuan Jin, Boqian Wang, Yunxiang Zhao, Jun Wu, Junjie Yue, Hongguang Ren · 2022 · Research Square
  33. Perspective on Accuracy of Past SARS-CoV-2 Evolutionary Predictions
    Juliette Blais-Savoie · 2023 · Journal of Undergraduate Life Sciences
  34. Impacts of viral pathogenesis and vaccine immunization on the host humoral immune response in SARS-CoV-2 and associated variants of concern (VOCs) infection
    Sougata Roy Chowdhury, Subhendu Chakrabarty, Modhurima Chakraborti, Amlan Kumar Das · 2023 · Elsevier eBooks
  35. Underlying driving forces of the SARS-CoV-2 evolution: immune evasion and ACE2 binding affinity
    Wentai Ma, Haoyi Fu, Fanchong Jian, Yunlong Cao, Mingkun Li · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  36. "Recent Progress in Therapeutics Strategies for Sars-Cov-2 Infection in the Omicron Era. A Review"
    Weimer LE · 2022 · Biomedical Journal of Scientific & Technical Research
  37. Spike glycoprotein of coronavirus of animals and sars-Cov-2
    Bramhadev Pattnaik, Suresh Puttahonnappa Kuralayanapalya, Chandan Shivamallu, Shiva Prasad Kollur, Mahendra Pal Yadav, Siju Susan Jacob, Awadh Bihari Pandey, Kirankere Ananthapadmanabha Shyamsundar, Sharanagouda Shiddanagouda Patil · 2022 · Indian Journal of Comparative Microbiology Immunology and Infectious Diseases
  38. SARS-CoV-2: Structure, Pathogenesis, and Diagnosis
    Aarthi Goverdhan · 2023 · Elsevier eBooks
  39. Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features
    Craig A. Magaret, Li Li, Allan C. deCamp, Morgane Rolland, Michal Juraska, Brian D. Williamson, James Ludwig, Cindy Molitor, David C. Benkeser, Alex R. Luedtke et al. · 2023 · Research Square
  40. Genomic characterization and phylogenomic relationship of the beta-variant of SARS- CoV-2 in Pakistan
    Nazia Fiaz, Imran Zahoor, Saima Naveed, Tahir Yaqub, Atia Basheer · 2023 · Research Square
  41. Mutational basis of serum cross-neutralization profiles elicited by infection or vaccination with SARS-CoV-2 variants
    Kshitij Wagh, Xiaoying Shen, James P. Theiler, Bethany Girard, Jean-Claude A. Marshall, David C. Montefiori, Bette Korber · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  42. Ensemble-Based Modeling of the SARS-CoV-2 Omicron BA.1 and BA.2 Spike Trimers and Systematic Characterization of Cryptic Binding Pockets in Distinct Functional States : Emergence of Conformation-Sensitive and Variant-Specific Allosteric Binding Sites
    Gennady M. Verkhivker, Mohammed Alshahrani, Grace Gupta · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  43. Clinical characteristics, management, and prevention of coronavirus disease 2019
    Wei‐jie Guan, Jianxing He · 2023 · Frigid Zone Medicine
  44. Characteristics of epitope dominance pattern and cross-variant neutralisation in 16 SARS-CoV-2 mRNA vaccine sera
    Mayo Yasugi, Yu Nakagama, Natsuko Kaku, Yuko Nitahara, Noritoshi Hatanaka, Shinji Yamasaki, Yasutoshi Kido · 2023 · Vaccine
  45. Screening Peptide Drug Candidates to Neutralize Whole Viral Agents : A Case study with SARS-CoV-2 Virus
    Cemile Elif Özçelik, Cemre Zekiye Araz, Özgür Yılmaz, Sevgi Gülyüz, Aykut Özkul, Urartu Özgür Şafak Şeker · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  46. Research on Variation of Sars-Cov-2 and Rapid Detection
    Jiashu Jiang, Virgia Wang · 2023 · International Conference on Bioinformatics and Biomedical Technology (ICBBT)
  47. Engineered Therapeutic Antibody Against SARS-CoV-2
    Monrat Chulanetra · 2023 · Current Clinical Microbiology Reports
  48. Notable variants of SARS COV 2 Virus - A Mini-Review
    Ebidor Ufoumanefe Lawani-Luwaji, Tolulope Alade, John B.U. · 2023 · African Journal of Biology and Medical Research
  49. SARS-CоV-2: what allowed the virus to cause a long-term pandemic?
    Д.В. Печкуров, A.A. Romanova, O.A. Savvateev, Тяжева Алена Александровна, Aleksandr V. Gorelov · 2023 · Russian Medical Inquiry
  50. Influenza a infections in the host : modeling and control approaches
    Gustavo Hernández Mejía · 2023
  51. Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies
    Aram Avila-Herrera, Jeffrey A. Kimbrel, Jose Manuel Martí, James B. Thissen, Edwin A. Saada, Tracy Weisenberger, Kathryn T. Arrildt, Brent W. Segelke, Jonathan Allen, Adam T Zemla et al. · 2024 · PLoS ONE
  52. Enhanced Antibody Response to the Conformational Non-RBD Region via DNA Prime-Protein Boost Elicits Broad Cross-Neutralization Against SARS-CoV-2 Variants
    Yun-Fei Ma, Kun Chen, Bowen Xie, Jiayi Zhu, Xuan He, Chunying Chen, Yuhe Renee Yang, Ye Liu · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  53. Screening Peptide Drug Candidates To Neutralize Whole Viral Agents: A Case Study with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
    Cemile Elif Özçelik, Cemre Zekiye Araz, Özgür Yılmaz, Sevgi Gülyüz, Pınar Özdamar, Ezgi Salmanlı, Aykut Özkul, Urartu Özgür Şafak Şeker · 2024 · ACS Pharmacology & Translational Science
  54. Broadly neutralizing antibodies against emerging delta-coronaviruses
    Megi Rexhepaj, Young‐Jun Park, Lisa Perruzza, Daniel E. Asarnow, Matthew McCallum, Katja Culap, Christian Saliba, Giada Leoni, Alessio Balmelli, Courtney N. Yoshiyama et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  55. Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
    Ketaren, Natalia E., Mast, Fred D., Fridy, Peter C., Olivier, Jean Paul, Sanyal, Tanmoy, Sali, Andrej, Chait, Brian T., Rout, Michael P., Aitchison, John D. · 2024
  56. Research progress in Fc‐effector functions against SARS‐CoV‐2
    Rongyuan Gao, Chenchen Feng, Zizhang Sheng, Feng Li, Dan Wang · 2024 · Journal of Medical Virology
  57. Etiological and immunopathogenetic aspects of multiorgan failure development in coronavirus disease (COVID-19)
    Тетяна Вадимівна Ащеулова, N. M. Herasymchuk, Oksana Kochubiei, U. S. Herasymchuk · 2024 · Zaporozhye Medical Journal
  58. N121T and N121S substitutions on the SARS‐CoV‐2 spike protein impact on serum neutralization
    Van Thi Lo, Hyun A. Lim, Seong Sik Jang, Min Chan Kim, Alain Chrysler Chamfort, Ha Yeon Kim, Da-Young Mun, Min-Chang Kang, Han Byul Lee, Sunjoo Kim et al. · 2024 · Journal of Medical Virology
  59. SARS-CoV-2 Mutations and Their Impacts on Virulence and Transmissibility of The Virus
    Sajjad Bahman, S. Farajnia, Effat Alizadeh, Hojjatollah Nozad Charoudeh, Mohammad Kazem Hosseini, B. Naghili · 2024 · ImmunoAnalysis
  60. SARS-CoV-2 spike protein in infectivity
    Alaa Muayad Altaie, Rania Hamdy, Mohamed Ibrahim Husseiny, Sameh S. M. Soliman · 2025 · Elsevier eBooks
  61. Within-Host Fitness and Antigenicity Shift Are Key Factors Influencing the Prevalence of Within-Host Variations in the SARS-CoV-2 S Gene
    Binbin Xi, Zhihao Hua, Dawei Jiang, Zixi Chen, Jinfen Wei, Yu-Huan Meng, Hongli Du · 2025 · Viruses
  62. Breakthrough infection elicits synergistic broadly neutralizing antibodies targeting non-dominant epitopes on RBD and NTD in an individual of inactivated SARS-CoV-2 vaccine
    Zuowei Wang, Hualong Feng, Ling Li, Yunjian Li, Maosheng Lu, Xixian Chen, Lin Hu, Yi Sun, Ruiping Du, Rongrong Qin et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  63. Differential Severity of Sars-Cov-2 Variant Infections in Children and Adults with Covid-19
    Charles Y. Chiu, Noah Brazer, Venice Servellita, Chengshi Jin, Abiodun Foresythe, Miriam Oseguera, Jenny Nguyen, Nanami Sumimoto, Hee Jae Huh, Andries Feder et al. · 2025 · SSRN Electronic Journal
  64. The pan-variant potential of light: 425 nm light inactivates SARS-CoV-2 variants of concern and non-cytotoxic doses reduce viral titers in human airway epithelial cells
    Nathan Stasko, Leslee Arwood, Nicole Jandick, Derry Spragion, Rachel C. Roberts, Mónica Setién, Ibrahim Henson, Abigail Annas, M. Leslie Fulcher, Marisa Brotton et al. · 2025 · mSphere
  65. Structural insights on the differentiation and reversion of conformational changes in SARS-CoV-2 spike protein models across variants occurring from December, 2019 to November, 2021
    M. Cueno, Kenichi Imai · 2025 · ImmunoInformatics
  66. Population-level toggling of T cell immune escape at human leukocyte antigen anchor residues in SARS-CoV-2 Spike proteins, in an ethnically diverse population region
    N. Ngandu, B. Fielding, P. van Heusden, Kuhle Mcinga, Kriheska Francis, G. Harkins · 2025 · PLoS Comput. Biol.
  67. A modular and universal platform for neutralizing-antibody profiling by quantifying antigen-receptor interactions via qPCR
    Xia Li, Qi Chen, Yating Zhu, Haofei Hong, Zhifang Zhou, Zhimeng Wu, Jie Shi · 2025 · Analytical Biochemistry
  68. Molecular detection, phylogenetic and whole genome sequence analyses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta variant isolated from domestic cats (Felis catus) in Egypt
    Mervat E. Hamdy, Mostafa R. Zaher, Rabab T. Hassanien, Mary A.N. Sargious, Samah F. Ali, Ahmed E. Kayed, Lotfi Allal, Momtaz A. Shahin, Samah Eid, Mohamed Ezzat El Zowalaty et al. · 2025 · Research in Veterinary Science
  69. First-generation N-terminal domain supersite public antibodies retain activity against Omicron-derived lineages and protect mice against Omicron BA.5 challenge
    Vincent Dussupt, Jaime L. Jensen, Paul V. Thomas, Letzibeth Mendez-Rivera, Kerri G. Lal, Michelle Zemil, Isabella Swafford, Joana Hernandez, Rajeshwer Singh Sankhala, Mekhala Rao et al. · 2025 · mBio
  70. Assessing the Impact of SARS-CoV-2 Spike Mutations on Antibody Binding: A Comparative Assessment of the Wuhan and JN.1 Variants’ Full-Length Spikes in a Multiplex Luminex Assay
    Gerald Waweru, Ruth K. Nyakundi, Bernadette Kutima, Sharon Owuor, Gloria Konyino, John N. Gitonga, Doreen I. Lugano, Angela W. Maina, Jennifer Musyoki, Lucy B. Ochola et al. · 2025 · Viruses
  71. High-stability, clamp-free soluble Sarbecovirus spike trimers and their potential for pan-Sarbecovirus vaccine development
    Christine Langer, Irene Boo, Tasnim Zakir, Charley Mackenzie-Kludas, Johnson Samuel, Stewart A. Fabb, CheeLeng Lee, Anupriya Aggarwal, Stuart Grant Turville, Colin William Pouton et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  72. Tracking down the origin and subsequent spread of SARS-CoV-2 lineage B.1.619
    Nena Bollen, Samuel Leandro Hong, Barney I. Potter, Reto Lienhard, Marie-Lise Tritten, Nicolas Sierro, Emmanuel Guedj, Rémi Dulize, David Bornand, Mehdi Auberson et al. · 2025 · Virus Evolution
  73. pH-induced structural changes in SARS-CoV-2 spike variants
    A. S. Oliveira, Lorenzo Tulli, Fiona L. Kearns, Lorenzo Casalino, Mia A. Rosenfeld, Imre Berger, C. Schaffitzel, Andrew D. Davidson, A. Haddrell, J. P. Reid et al. · 2025 · bioRxiv
  74. Additional file 2 of Phylogenetic analysis and comparative genomics of SARS-CoV-2 from survivor and non-survivor COVID-19 patients in Cordoba, Argentina
    Nadia B. Olivero, Ana Silvia Gonzalez-Reiche, Re, Viviana E., Gonzalo Castro, Pisano, María B., Paola E. Sicilia, María Gabriela Barbás, Zenab Khan, Adriana van de Guchte, Dutta, Jayeeta et al. · 2022 · Figshare
  75. Additional file 3 of Phylogenetic analysis and comparative genomics of SARS-CoV-2 from survivor and non-survivor COVID-19 patients in Cordoba, Argentina
    Nadia B. Olivero, Ana Silvia Gonzalez-Reiche, Re, Viviana E., Gonzalo Castro, Pisano, María B., Paola E. Sicilia, María Gabriela Barbás, Zenab Khan, Adriana van de Guchte, Jayeeta Dutta et al. · 2022 · Figshare
  76. Additional file 1 of Antibody engineering improves neutralization activity against K417 spike mutant SARS-CoV-2 variants
    Li, Lili, Gao, Meiling, Jiao, Peng, Zu, Shulong, Deng, Yong-qiang, Dingyi Wan, Cao, Yang, Duan, Jing, Saba Roghiyh Aliyari, Li, Jie et al. · 2022 · Figshare
  77. Additional file 2 of Evidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapies
    Shuchen Feng, Gail Reid, Nina M. Clark, Harrington, Amanda, Susan L. Uprichard, Susan C. Baker · 2024 · Figshare
  78. Additional file 1 of Evidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapies
    Shuchen Feng, Gail Reid, Nina M. Clark, Harrington, Amanda, Susan L. Uprichard, Susan C. Baker · 2024 · Figshare
  79. Additional file 4 of Phylogenetic analysis and comparative genomics of SARS-CoV-2 from survivor and non-survivor COVID-19 patients in Cordoba, Argentina
    Nadia B. Olivero, Ana Silvia Gonzalez-Reiche, Re, Viviana E., Gonzalo Castro, Pisano, María B., Paola E. Sicilia, María Gabriela Barbás, Zenab Khan, Adriana van de Guchte, Jayeeta Dutta et al. · 2022 · Figshare
  80. Structure-guided design of a bivalent SARS-CoV-2 mRNA vaccine with NTD stabilizing mutations enhances broad immunity
    Jinah Yeo, Mi-Ran Yun, Seo-Yeon Kim, Jong-Hyun Seok, Ji Hyang Jeon, Taeyoung Lee, Jeonghun Kim, Kisoon Kim, Man‐Seong Park, Dokeun Kim et al. · 2026 · Frontiers in Immunology
  81. AddaVax, AddaS03, and Alum Effectively Enhance Cross-Reactive and Cross-Neutralizing Antibody Responses Against SARS-CoV-2 Induced by the Inactivated NDV-HXP-S Vaccine in Mice
    José Luis Martínez-Guevara, Tsoi Ying Lai, Mitali Mishra, Stefan Slamanig, Irene González‐Domínguez, Adam Abdeljawad, Minh Thu Hoang, Gagandeep Singh, Shreyas Kowdle, Lee Benhur et al. · 2026 · Vaccines
  82. Host Glycan–Lectin Interplay in SARS-CoV-2 Infection
    H. R. Oh, Vu Thi Thuy Tien, Showkot Ahmed, Jisoo Choi, Ki‐Jun Ryu, Jinsung Yang · 2026 · International Journal of Molecular Sciences
  83. Host proteins associated with strong neutralizing SARS-CoV-2 antibody responses in a South African cohort
    Afrah Khairallah, Zesuliwe Jule, Alice Piller, Mallory P. Bernstein, Kajal Reedoy, Yashica Ganga, Sashkia R. Balla, Prudence Kgagudi, Bernadett Isabel Gosnell, Farina. Karim et al. · 2026 · Communications Medicine
  84. Defining the Antigenic Topology and Prospective Binding Breadth of Vaccination-induced SARS-CoV-2 Neutralizing Antibodies
    Deepika Jaiswal, Clara G. Altomare, Daniel C. Adelsberg, Iden A. Sapse, Florian Krammer, Viviana R. Simon, Ali H. Ellebedy, Goran Bajic · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  85. Determinants of natural killer cell-mediated antibody dependent cellular cytotoxicity in SARS-CoV-2 antibodies
    Delphine M Depierreux, F. Ruiz, M. Lilly, J. Guenthoer, V. Chohan, J. Overbaugh · 2026 · PLoS Pathogens
  86. Machine learning-based insight into the evolutionary divergence of spike protein models in SARS-CoV-2 omicron BA.1 and BA.2 sublineages
    Marni E. Cueno, Haruka Tamura, Kenichi Imai · 2026 · In Silico Research in Biomedicine
  87. Conservation of Bacterial Lipopolysaccharide Binding by SARS-CoV-2 Spike across Major Viral Variants
    Firdaus Samsudin, Ganna Petruk, Li Rui, Artur Schmidtchen, Peter John Bond · 2026 · Computational and Structural Biotechnology Journal
  88. Contrasting effects of SARS-CoV-2 vaccination vs. infection on antibody and TCR repertoires
    Jasper Braun, Elliot D. Hill, Elisa Contreras, Michie Yasuda, Alexandra Morgan, Sarah Ditelberg, Ethan Winter, Cody J. Callahan, Gabrielle Mazzoni, Andrea Kirmaier et al. · 2026 · PLoS ONE
  89. Caractérisation des activités antivirales des anticorps anti-VIH-1 et anti-SARS-CoV-2
    Jérémy Dufloo · 2021 · theses.fr (ABES)
  90. Caractérisation de la réponse lymphocytaire B mémoire contre le SARS-CoV-2 après infection ou vaccination
    Aurélien Sokal · 2022 · theses.fr (ABES)
  91. Prise en charge d’une infection virale chronique (BK polyomavirus) et d’une infection virale aigue (SARS-CoV-2) dans une population de transplantés rénaux
    Iliès Benotmane · 2022
  92. Caractérisation de la diversité génétique de SARS-CoV-2 dans des échantillons cliniques
    Wahiba Bader · 2022
  93. The mechanisms and consequences of SARS-CoV-2 induced cell-to-cell fusion
    William Bolland · 2024
  94. Computational design of an ultrapotent deltacoronavirus miniprotein inhibitor
    Nathan G Avery, Courtney N. Yoshiyama, Ashley L Taylor, Young‐Jun Park, Daniel E. Asarnow, Lisa Perruzza, Jack T Brown, Davide Corti, Fabio Benigni, Tyler N. Starr et al. · 2026 · Proceedings of the National Academy of Sciences
  95. Defining the Antigenic Topology and Prospective Binding Breadth of Vaccination-induced SARS-CoV-2 Neutralizing Antibodies
    Deepika Jaiswal, Clara G. Altomare, Daniel C. Adelsberg, Iden A. Sapse, Florian Krammer, Viviana R. Simon, Ali H. Ellebedy, Goran Bajic · 2026 · eLife
  96. Defining the Antigenic Topology and Prospective Binding Breadth of Vaccination-induced SARS-CoV-2 Neutralizing Antibodies
    Deepika Jaiswal, Clara G. Altomare, Daniel C. Adelsberg, Iden A. Sapse, Florian Krammer, Viviana R. Simon, Ali H. Ellebedy, Goran Bajic · 2026 · eLife
  97. KmerSignificance Score: A discriminative and biologically-informed framework for viral k-mer prioritization
    Dylan Lebatteux, F. Corso, Hugo Soudeyns, Isabelle Boucoiran, S. Gantt, A. Diallo · 2026 · bioRxiv
  98. From weak but broad to potent and universal: A trispecific antibody against conserved SARS-CoV-2 spike epitopes
    Xiaodong Tian, Chunmei Wang, Pu Han, Honghui Liu, Lili Wu, Xiaoyun Wang, Shufan Yu, Yanning zhang, Binbin Zhao, Jiangning Liu et al. · 2026 · Molecular Therapy
  99. SARS-CoV-2 intra-host recombination promotes epistatic spike interactions and temperature-dependent adaptation
    Mazharul Altaf, Mark Tsz Kin Cheng, Luis Daniel González-Vázquez, Jesu Castin E, Steven A. Kemp, Ryan Hisner, Darren Patrick Martin, Lipi Thukral, Bo Meng, Ravindra K. Gupta · 2026 · Cell Reports
  100. Cell-Mediated Immunity of mRNA-1283 Vaccine Encoding SARS-CoV-2 Spike Receptor-Binding and N-Terminal Domains in Preclinical and Clinical Studies
    Alec W. Freyn, Yadunanda Budigi, Bethany Girard, Genesis Santos, Cathal Harmon, Md Mahmudul Hasan, Shannon McGrath, Yamuna Devi Paila, Andrea Carfı́, Darin Edwards et al. · 2026 · The Journal of Infectious Diseases